Milestones in movement disorders clinical trials: advances and landmark studies.
about
Nocebo as a potential confounding factor in clinical trials for Parkinson's disease treatment: a meta-analysis.Digitized Spiral Drawing: A Possible Biomarker for Early Parkinson's Disease.The futility study--Progress over the last decade.Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson diseaseVascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's diseaseAlzheimer's disease drug development: translational neuroscience strategies.
P2860
Milestones in movement disorders clinical trials: advances and landmark studies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Milestones in movement disorders clinical trials: advances and landmark studies.
@en
Milestones in movement disorders clinical trials: advances and landmark studies.
@nl
type
label
Milestones in movement disorders clinical trials: advances and landmark studies.
@en
Milestones in movement disorders clinical trials: advances and landmark studies.
@nl
prefLabel
Milestones in movement disorders clinical trials: advances and landmark studies.
@en
Milestones in movement disorders clinical trials: advances and landmark studies.
@nl
P2860
P356
P1433
P1476
Milestones in movement disorders clinical trials: advances and landmark studies.
@en
P2093
Kathryn B Wunderle
P2860
P304
P356
10.1002/MDS.23727
P407
P577
2011-05-01T00:00:00Z